Stock Price & Analysis

Based on the recent data and news, here's a comprehensive analysis of FMC stock:

Recent Price Performance and Technical Analysis

FMC stock has experienced a significant decline, falling 33.5% in a single day following its Q4 2024 earnings release. The stock is currently trading at $37.97, near its 9-year low, with technical indicators showing bearish signals:

• RSI-14 at 29.91 indicates oversold conditions
• MACD is negative at -3.97, suggesting continued downward momentum
• All major moving averages (5,10,20,60,200-day) are trending downward

Fundamental Analysis

The company's Q4 2024 performance and 2025 outlook have raised concerns:

• Q4 Revenue: $1.22B (up 7% YoY but below $1.31B consensus)
• Q4 Adjusted EPS: $1.79 (beat expectations of $1.60)
• 2025 Guidance:
  • Revenue: $4.15B-$4.35B
  • Adjusted EPS: $3.26-$3.70
  • Both metrics significantly below analyst expectations

Analyst Sentiment

Recent analyst actions have been predominantly bearish:

• 11 analysts coverage: 1 Strong Buy, 2 Somewhat Bullish, 7 Neutral, 1 Bearish
• Average price target reduced to $56.64 (range: $46-$69)
• Multiple firms including B of A Securities, BMO Capital, and Morgan Stanley have lowered their price targets

Business Segments Analysis

Revenue Distribution (FY2022):

• Insecticides: 57.68% ($3.35B)
• Herbicides: 28.47% ($1.65B)
• Fungicides: 6.62% ($0.38B)
• Plant Health: 4.04% ($0.23B)
• Other: 3.21% ($0.19B)

Investment Outlook

The stock appears oversold from a technical perspective, but several fundamental challenges remain:

• Inventory destocking issues affecting customer behavior
• Unfavorable foreign exchange impacts
• Conservative 2025 guidance suggesting limited growth

While the current P/S ratio of 1.0x (vs. historical 2.2x) suggests potential value, the near-term headwinds and negative momentum warrant caution.

Recommendation: Hold. While valuations appear attractive after the recent selloff, it's advisable to wait for signs of business stabilization and technical trend reversal before initiating new positions.

Based on the recent data and news, here is the price prediction for FMC stock in 2025:

FMC stock is expected to trade in the $42-45 range by end of 2025, representing a potential upside of 10-18% from current levels, driven by expected recovery in agricultural demand and inventory normalization. The company's recent Q4 earnings showed mixed results with revenue missing estimates but earnings beating expectations. While near-term headwinds persist with weak Q1 2025 guidance of $0.05-0.15 EPS versus $0.94 estimates, the stock appears oversold after falling 34% to 9-year lows.

The stock currently trades at attractive valuations of 1.0x sales versus historical average of 2.2x, suggesting significant upside potential once agricultural market conditions improve. However, high debt levels and potential dividend sustainability concerns could limit near-term price appreciation.

The S1 support level for FMC Stock is $36.39 ,The R1 resistant level for FMC Stock is $38.53.

As of the end of day on 2025-02-27, the price of FMC Stock was $37.61.

The target price for FMC Stock according to analyst rating is 48.00, with the highest price target at 65.00 and the lowest at 36.00. Analysts have a Hold rating on FMC Stock overall.

The market cap of FMC is $4.7B.

Based on the provided data and recent market developments, here's a comprehensive analysis of FMC's valuation:

Current Market Position

• Trading at $37.97, down 0.73% in regular trading session [Relevant Data]
• Stock has declined significantly, falling 43% since the beginning of 2024
• Currently trading at a substantial discount compared to historical levels

Valuation Metrics

• Market Cap: $4.7B
• P/S Ratio: 1.0x (vs. historical 5-year average of 2.2x)
• Forward P/E: ~11x based on 2025 EPS guidance of $3.48

Recent Performance & Catalysts

• Q4 2024 results triggered a massive 33.5% single-day drop
• Revenue of $1.22B missed forecasts of $1.34B
• 2025 guidance disappointed: Revenue $4.15B-$4.35B, below consensus of $4.40B

Analyst Sentiment

• Consensus rating is "Moderate Buy" from 18 analysts
• Price targets range from $48 to $72, with mean target of $50.31
• Recent downgrades from multiple firms including Barclays lowering target to $48

Technical Analysis

• RSI(14) at 29.91 indicates oversold conditions
• Trading below all major moving averages (5,10,20,60,200-day)
• MACD showing negative momentum with -3.97 reading

Conclusion: FMC appears UNDERVALUED based on:

1. Trading significantly below historical valuation multiples
2. Oversold technical conditions
3. Strong analyst upside potential (37.4% to mean price target)
4. Solid business fundamentals despite near-term challenges

However, investors should note the significant headwinds:

• Inventory destocking issues
• Pricing pressures
• Margin concerns
• High debt levels raising potential credit rating concerns

FMC Corporation is an agricultural sciences company. It is engaged in providing solutions to growers with a product in crop protection, crop enhancement, and professional pest and turf management. It develops, markets, and sells all three classes of crop protection chemicals (insecticides, herbicides, and fungicides) and biologicals, crop nutrition, and seed treatment products, which is grouped as plant health. Its insecticides are used to control a range of pests, while its herbicide portfolio primarily targets a variety of difficult-to-control weeds. Its product portfolio features two diamide-class molecules, namely Rynaxypyr (chlorantraniliprole) and Cyazypyr (cyantraniliprole) actives. Cyazypyr active contains brands, under the trademarks Verimark, Benevia, and Exire. Fungicides are used for the protection of crops, including cereals, fruits, and vegetables from fungal disease. Herbicides are used for the protection of crops, including cotton, sugarcane, rice, corn, and soybeans.

Based on the provided data and recent market developments, here's a comprehensive analysis for FMC's stock price prediction for 2030:

Current Market Position and Recent Performance

FMC stock has experienced significant decline, currently trading at $37.97. The stock has fallen dramatically after its Q4 2024 earnings release, dropping 34% in a single day to reach its lowest level since 2016.

Key Drivers for 2030 Projection

1. Business Fundamentals:

• Revenue growth challenges with Q4 2024 revenue of $1.22 billion, below analyst expectations
• Margin expansion potential shown by Q4 EBITDA margin improvement of 550 bps to 27.7%
• Inventory destocking issues affecting global performance

2. Market Position:

• One of the five largest patented crop protection companies globally
• Strong R&D pipeline in biologicals and new product development
• Geographic diversification across markets

2030 Price Prediction: FMC stock is projected to reach $85-90 by 2030, representing a ~125% increase from current levels, driven by expected recovery in agricultural markets, normalized inventory levels, and the company's strong market position in crop protection solutions.

The prediction is based on:

1. Historical valuation metrics showing current P/S ratio of 1.0x vs. 5-year average of 2.2x
2. Expected agricultural market recovery and normalization of inventory levels
3. Company's strategic position in crop protection and continued R&D investments

FMC has a total of 6600 employees.